Edition:
United States

Evogene Ltd (EVGN.OQ)

EVGN.OQ on NASDAQ Stock Exchange Global Market

3.40USD
15 Dec 2017
Change (% chg)

$-0.03 (-0.87%)
Prev Close
$3.43
Open
$3.40
Day's High
$3.42
Day's Low
$3.38
Volume
105,914
Avg. Vol
3,195
52-wk High
$5.76
52-wk Low
$3.37

Chart for

About

Evogene Ltd. (Evogene) is a biotechnology company for the improvement of crop productivity. The Company is engaged in developing seed traits for improved yield and abiotic stress tolerance, seed traits for biotic stress resistance, herbicides and bio-stimulants. The Company operates a seed business under its subsidiary Evofuel... (more)

Overall

No Ratios Available.

Financials

  Industry Sector
P/E (TTM): -- 8.43 16.04
EPS (TTM): -- -- --
ROI: -- 9.01 34.69
ROE: -- 9.48 15.46

BRIEF-Evogene Q3 loss per share $0.20

* Evogene Ltd - ‍in 2018, Evogene expects net cash usage of $14 million to $16 million

Nov 22 2017

BRIEF-Evogene posts Q2 ‍loss per share $0.18​

* ‍Total revenues for Q2 of 2017 were $1.2 million, compared to $1.8 million for Q2 in 2016​

Aug 10 2017

BRIEF-Evogene ltd - entered into a multiyear collaboration with DuPont Pioneer

* Evogene Ltd - entered into a multiyear collaboration with DuPont Pioneer

Jul 26 2017

BRIEF-Evogene Ltd reaches an important milestone in its crop disease collaboration with Monsanto Company​

* Evogene Ltd- ‍company reached an important milestone in its crop disease collaboration with Monsanto Company​

Jul 11 2017

BRIEF-Evogene announces positive results in insect control seed trait program

* Evogene Ltd announces positive results in insect control seed trait program and advancement to Phase-I of First Toxin against Western Corn Rootworm

Jun 20 2017

Earnings vs. Estimates